Information Provided By: 
Fly News Breaks for February 22, 2016
STJ
Feb 22, 2016 | 07:43 EDT
Local Medicare Administrative Contractor Novitas has decided to deny coverage of CardioMEMs in its final ruling, Leerink analyst Danielle Antalffy tells investors in a research note. While a near-term "bump in the road," the key to CardioMEMs' growth over the long term lies with the National Coverage Decision, the analyst contends. She reiterates an Outperform rating on St. Jude Medical with a $68 price target.
News For STJ From the Last 2 Days
There are no results for your query STJ
